ELV vs HOTH · P/E 18, rev $199.13B vs rev $1.24B
Elevance Health Inc (ELV) versus Hoth Therapeutics Inc (HOTH) — a side-by-side from cached financials, not a winner call.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. HOTH currently screens at market cap $15.5M.
Not investment advice. Open the ELV and HOTH stock pages for the full models.
Not investment advice.